As of Apr 20
| -0.40 / -0.88%|
The 3 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 68.00, with a high estimate of 83.00 and a low estimate of 60.00. The median estimate represents a +50.68% increase from the last price of 45.13.
The current consensus among 4 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.